Terms: = Pancreatic cancer AND TFEB, TCFEB, 7942, ENSG00000112561, P19484, AlphaTFEB AND Treatment
4 results:
1. DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.
Bildik G; Gray JP; Mao W; Yang H; Ozyurt R; Orellana VR; De Wever O; Carey MS; Bast RC; Lu Z
Autophagy; 2024 Mar; 20(3):675-691. PubMed ID: 38169324
[TBL] [Abstract] [Full Text] [Related]
2. LncRNA XXYLT1-AS2 promotes tumor progression via autophagy inhibition through ubiquitinated degradation of tfeb in hepatocellular carcinoma.
Li X; Wu Y; Wang P; Li Y; Gu J; Zhang Y; Yan S; Hu P
Clin Transl Oncol; 2024 Mar; 26(3):698-708. PubMed ID: 37540409
[TBL] [Abstract] [Full Text] [Related]
3. A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer.
Wang T; Qin Y; Ye Z; Jing DS; Fan GX; Liu MQ; Zhuo QF; Ji SR; Chen XM; Yu XJ; Xu XW; Li Z
Acta Pharmacol Sin; 2023 Aug; 44(8):1536-1548. PubMed ID: 37012494
[TBL] [Abstract] [Full Text] [Related]
4. Role of tfeb-driven autophagy regulation in pancreatic cancer treatment.
Klein K; Werner K; Teske C; Schenk M; Giese T; Weitz J; Welsch T
Int J Oncol; 2016 Jul; 49(1):164-72. PubMed ID: 27175909
[TBL] [Abstract] [Full Text] [Related]
